Under Performance of Anti Tuberculosis Vaccine MVA85A in BCGPrimed Subjects: A Commentary

Publisher： Bentham Science Publishers

E-ISSN： 1875-631x|12|1|56-60

ISSN： 1573-3955

Source： Current Immunology Reviews, Vol.12, Iss.1, 2016-03, pp. : 56-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Tuberculosis Vaccine Development

By  

Current Respiratory Medicine Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 109-116

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Utility of Mycobacterium w Vaccine in Control of Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 183-188

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis after anti-TNF therapy

By Pamuk Ömer   Dönmez Salim  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 747-747

Springer Publishing Company

Access to resources Recommend Favorite

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs

By Imperiale B. R.  

The International Journal of Tuberculosis and Lung Disease, Vol. 17, Iss. 8, 2013-08 ,pp. : 1088-1093

International Union Against Tuberculosis and Lung Disease

Access to resources Recommend Favorite

Current Status of Anti-Tuberculosis Therapy: A Patent Analysis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite